# A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

> clinical trial · VERIFIED · 2026-07-13

Status: RECRUITING · Sponsor: AbbVie · Condition: Acute Myeloid Leukemia

- Company: AbbVie
- Sector: Acute Myeloid Leukemia
- Primary source: https://clinicaltrials.gov/study/NCT07306832

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.